Patents by Inventor Rami Burstein

Rami Burstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9061025
    Abstract: A method for treating a headache by selecting a patient determined to be responsive to administration of a botulinum neurotoxin for treatment of a headache by determining that the patient has or has a propensity to have an imploding headache and/or an ocular headache pain and administering a botulinum toxin to the patient, thereby treating the headache. A method for selecting from a population of patients with headache or with a propensity to have a headache, those patients whose headache will respond to administration of a botulinum neurotoxin by identifying from a population of patients with headache or with a propensity to have a headache those patients who have or who have a propensity to have an imploding headache pain and/or an ocular headache pain.
    Type: Grant
    Filed: August 31, 2006
    Date of Patent: June 23, 2015
    Assignee: Allergan, Inc.
    Inventors: Rami Burstein, Catherine C. Turkel, Mitchell F. Brin
  • Publication number: 20140303124
    Abstract: The present invention is related to compositions and methods for treating or reducing the likelihood of a migraine, reducing the severity of migraine, reducing the frequency of migraines, reducing the duration of migraine, and ameliorating the symptoms of a migraine. The methods and compositions of the present invention may also be used to treat or prevent a condition characterized by increased cardiovascular risk or endothelial dysfunction and musculoskeletal symptoms.
    Type: Application
    Filed: May 20, 2014
    Publication date: October 9, 2014
    Applicant: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Rami BURSTEIN, Catherine BUETTNER
  • Publication number: 20120329764
    Abstract: The present invention is related to compositions and methods for treating or reducing the likelihood of a migraine, reducing the severity of migraine, reducing the frequency of migraines, reducing the duration of migraine, and ameliorating the symptoms of a migraine. The methods and compositions of the present invention may also be used to treat or prevent condition characterized by increased cardiovascular risk or endothelial dysfunction and musculoskeletal symptoms.
    Type: Application
    Filed: January 10, 2011
    Publication date: December 27, 2012
    Applicant: BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
    Inventors: Rami Burstein, Catherine Buettner
  • Publication number: 20080057084
    Abstract: A method for treating a headache by selecting a patient determined to be responsive to administration of a botulinum neurotoxin for treatment of a headache by determining that the patient has or has a propensity to have an imploding headache and/or an ocular headache pain and administering a botulinum toxin to the patient, thereby treating the headache. A method for selecting from a population of patients with headache or with a propensity to have a headache, those patients whose headache will respond to administration of a botulinum neurotoxin by identifying from a population of patients with headache or with a propensity to have a headache those patients who have or who have a propensity to have an imploding headache pain and/or an ocular headache pain.
    Type: Application
    Filed: August 31, 2006
    Publication date: March 6, 2008
    Applicant: ALLERGAN, INC.
    Inventors: Rami Burstein, Catherine C. Turkel, Mitchell F. Brin